COMMUNIQUÉS West-GlobeNewswire

Portola Pharmaceuticals Appoints Sheldon Koenig as Chief Commercial Officer
28/01/2019
Brings to Portola 30 Years’ Commercial Experience and Key Therapeutic Area Launch Expertise SOUTH SAN FRANCISCO, Calif., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA) today announced [...]
Protech Home Medical Announces Record 11X Adjusted EBITDA Growth and Significant Operating Cash Flow Growth in Year End Audited Financials
28/01/2019
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. CINCINNATI, Jan. 28, 2019 (GLOBE NEWSWIRE) -- Protech Home [...]
Dr. Mitesh Borad Joins OncBioMune Scientific Advisory Board
28/01/2019
BATON ROUGE, La., Jan. 28, 2019 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary [...]
Cannabix Technologies Completes Breath Collection Unit and Provides Update
28/01/2019
The Cannabix Marijuana Breathalyzer system is being developed to give law enforcement and employers a tool to enforce public safety VANCOUVER, British Columbia, Jan. 28, 2019 (GLOBE NEWSWIRE) -- Cannabix Technologies [...]
Golden Leaf Holdings Announces Appointment of Larry H. Martin to Board of Directors
28/01/2019
PORTLAND, Ore., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a cannabis company with cultivation, production and retail operations built around [...]
BIOLIFE4D Appoints Management Advisory Board
28/01/2019
Company names Dr. Michael Davidson, Mr. Stephen Simes, Dr. Mark Weinberg, and Mr. Bruce Werner as strategic advisors CHICAGO, Jan. 28, 2019 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue [...]
Bellerophon to Present Clinical Data Supporting Actigraphy as a Clinically Meaningful Endpoint to Detect Improvements in Pulmonary Fibrosis Patients
28/01/2019
Actigraphy is Being Utilized to Evaluate Multiple Clinically Meaningful Activity Parameters in the Ongoing INOpulse® Phase 2b Clinical Trial for Treatment of Pulmonary Hypertension Associated with Interstitial Lung [...]
New Clinical Trial Finds Milestone Scientific’s CompuFlo® Instrument a Safe Alternative to Current Standards of Care
28/01/2019
Publication in top ranked Anesthesia & Analgesia Journal compares CompuFlo pressure sensing to fluoroscopy and loss of resistance LIVINGSTON, N.J., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: [...]
Allogene Therapeutics, in Collaboration with Servier, Announces FDA Clearance of the IND for ALLO-501, an anti-CD19 Allogeneic CAR T (AlloCAR T™) Therapy
28/01/2019
Allogene to Initiate the ALPHA Study for ALLO-501 in Relapsed/Refractory Non-Hodgkin Lymphoma ALLO-647, Allogene’s Proprietary anti-CD52 Antibody, Will be Administered as Part of the Lymphodepletion Regimen SOUTH SAN [...]
How Cannabinoids Could Replace Opioids -- CFN Media
28/01/2019
SEATTLE, Jan. 28, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
BioTelemetry, Inc. to Acquire Geneva Healthcare, Inc.
28/01/2019
Creates Most Comprehensive Connected Health Solution in Cardiology Market MALVERN, Pa., Jan. 28, 2019 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote and wireless medical technology company [...]
Advantis Corp. Says Orders Doubled to Start the Year
28/01/2019
NEWPORT BEACH, CA, Jan. 28, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – ADVANTIS CORPORATION (OTC PINK: ADVT) announced today that orders from existing customers are already double that of the fourth quarter. Advantis [...]
Summit Healthcare selects 2bPrecise for Pharmacogenomics
28/01/2019
Arizona-based provider launches precision medicine initiative for improved outcomes and patient experience CHICAGO and PITTSBURGH and SHOW LOW, Ariz., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Allscripts Healthcare Solutions, [...]
electroCore to Present at Noble Capital Markets’ Fifteenth Annual Investor Conference
28/01/2019
BASKING RIDGE, N.J., Jan. 28, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (“electroCore”) (Nasdaq:ECOR), a commercial-stage bioelectronic medicine company, today announced Chief Executive Officer, Frank Amato and Chief [...]
Medovex Corporation Receives an Additional $2.9 Million Under Existing Securities Purchase Agreement
28/01/2019
ALPHARETTA, Ga., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Medovex Corporation (OTCQB: MDVX) (“Medovex” or the “Company”) today announced that on January 18, 2019, the Company entered into a securities purchase agreement with [...]
Israel Passes Cannabis Export Law, Paving Path for Aura’s European Distribution
28/01/2019
TORONTO, Jan. 28, 2019 (GLOBE NEWSWIRE) -- Aura Health Inc. (the “ Company ” or “ Aura ”) ( CSE:BUZZ ) is pleased with the final approval of Israel’s export law for medical cannabis. On Sunday, January 27, the Israeli [...]
Avinger’s Pantheris SV (Small Vessel) Featured in Live Case Transmission at Leipzig Interventional Course (LINC) 2019
28/01/2019
REDWOOD CITY, Calif., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that its Pantheris® SV (Small [...]
Xenon Provides Key Regulatory Updates on XEN007 and XEN1101
28/01/2019
FDA Grants Rare Pediatric Disease Designation to XEN007 for Alternating Hemiplegia of Childhood (AHC); Xenon Eligible to Apply for Priority Review Voucher IND for XEN1101 Accepted; Site Selection and Patient Enrollment [...]
Chiesi in the Community Donates approximately $850,000 in 2018
28/01/2019
The company’s CSR efforts amplified by investing in the local community and therapeutic areas CARY, N.C., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Chiesi USA, Inc. (key-A-zee) , a Cary-based specialty pharmaceutical company, [...]

Pages